Drug shows potential to delay onset or progression of Alzheimer's disease
Monday, March 11, 2013 - 21:30
in Health & Medicine
An anti-atherosclerosis drug greatly reduced blood-brain barrier (BBB) leaks in animal models with diabetes and hypercholesterolemia and linked BBB permeability with amyloid peptide deposits at the site of early Alzheimer's pathology.